查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1930065

全球注射筆針市場：市場規模、市場佔有率、成長率、產業分析、按類型、應用和地區劃分的考量因素以及未來預測（2025-2034）

Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

注射筆針市場成長驅動因素

2025年全球注射筆針市場規模為24.1億美元。在本報告涵蓋的預測期內，預計該市場規模將在2026年增長至25.6億美元，並在2034年達到45.8億美元，2026年至2034年的複合年增長率（CAGR）為7.50%。北美地區在2025年佔全球市場39.60%的佔有率，這主要得益於注射給藥裝置的高滲透率以及許多成熟醫療器材製造商的強大影響力。

注射筆針頭是與注射筆配合使用的一次性醫療器械，用於注射胰島素、GLP-1受體激動劑、生長激素和其他注射療法等藥物。這些針頭在單次或有限使用後需要更換，這顯著增加了持續的需求。糖尿病、骨質疏鬆症、肥胖症和荷爾蒙缺乏症等慢性疾病的日益普遍是市場擴張的主要驅動因素。

市場驅動因素

全球慢性疾病的增加是注射筆針頭需求的主要驅動因素。預計到2025年，糖尿病將成為注射筆針頭使用量最大的疾病，這主要是由於患者長期依賴胰島素。 GLP-1注射療法在糖尿病和肥胖症治療中的日益普及，進一步增加了對注射筆給藥系統的依賴。

市場參與者正積極透過收購、合作和新產品發布來擴展其產品組合。例如，MTD Medical Technology and Devices S.p.A. 透過收購胰島素筆針和血糖監測業務，並加強其在多個地區的供應鏈，鞏固了其在胰島素筆針領域的市場地位。此外，胰島素筆針作為非處方藥在已開發市場日益普及，也促進了其可及性和銷售量的成長。

市場限制因子

儘管市場需求強勁，胰島素筆針市場仍存在一些限制因素。針刺傷、注射部位反應和感染傳播等風險仍然是患者和醫護人員關注的主要問題。不正確的注射技術和在同一部位重複注射會導致脂肪增生和皮膚感染等併發症。此外，包括口服糖尿病和骨質疏鬆症藥物在內的替代療法的出現，也繼續限制了胰島素筆針在某些患者群體中的市場滲透率。

細分市場分析

依產品類型劃分：

標準胰島素筆針保持其主導地位，預計到 2026 年將佔全球 67.97% 的市場佔有率。其廣泛應用主要得益於其成本效益和糖尿病患者的高接受度。由於人們對預防針刺傷的意識不斷提高，預計安全胰島素筆針的市場成長速度將更快。

依藥物類型劃分：

胰島素細分市場預計將在 2026 年佔主導地位，市佔率達 75.39%，這反映了糖尿病管理對胰島素的高度依賴。預計到 2034 年，GLP-1 及其他注射類藥物市場將持續成長。

依疾病分類：

糖尿病作為主要適應症，在 2026 年佔全球需求的 83.59%。這一主導地位得益於糖尿病盛行率的上升以及製造商在胰島素輸注系統方面的持續創新。

依針頭尺寸分類：

由於疼痛感和肌肉注射風險較低，4 毫米針頭在 2026 年佔了 49.61% 的市場佔有率。 6 毫米針頭因其在安全性和給藥效率方面的平衡性而需求不斷增長。

依分銷管道分類：

2025 年，零售藥局將主導市場，這主要得益於其對病患便利性和非處方藥供應的重視。受送貨上門的便利性和數位化醫療普及的推動，預計到 2034 年，線上藥局將快速成長。

區域趨勢

北美憑藉其先進的醫療基礎設施和強大的製造商實力，仍然是關鍵區域。在 Envector 和 Cardinal Health 等公司的支持下，到 2026 年，該地區市場規模達到 9.6 億美元。

歐洲預計到 2034 年將保持穩定成長，這主要得益於糖尿病的高發生率和人們對胰島素自我注射療法的日益青睞。亞太地區預計將呈現最高的成長率，這得益於不斷擴大的患者群體、人們對注射療法的認識不斷提高，以及中國、印度、日本和其他地區對製藥業的投資增加。

主要公司趨勢

競爭格局包括 Novo Nordisk A/S、Terumo Corporation、BD、Owen Mumford 和 B. Braun SE。這些公司將持續專注於創新、提升安全設計並拓展全球分銷網絡。

回報內容

"全球注射筆針頭市場" 報告詳細分析了2025年、2026年和2034年的市場規模趨勢，以及細分市場分析、區域展望、競爭格局和新冠疫情的影響。本報告也涵蓋了併購、合作、新產品發布等主要產業趨勢，這些趨勢將在預測期內影響市場動態。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家和地區糖尿病盛行率（2025 年）
  • 主要國家和地區肥胖盛行率（2025 年）
  • 主要產業趨勢：併購、業務合作關係等
  • 新冠疫情對市場的影響

第五章 全球胰島素筆針市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 標準胰島素筆針
    • 安全胰島素筆針
  • 市場分析、洞察與預測：依藥物類型劃分
    • 胰島素
    • GLP-1
    • 生長激素
    • 其他
  • 市場分析、洞察與預測：依疾病劃分
    • 糖尿病
    • 肥胖症
    • 荷爾蒙缺乏症
    • 其他
  • 市場分析、洞察與預測：依針頭尺寸劃分
    • 4毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市場分析、洞察與預測：依銷售管道劃分
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 市場分析、洞察與預測：按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 澳大利亞
    • 印度
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 南非
    • 海灣合作委員會 (GCC) 國家
    • 其他拉丁美洲國家

第十一章：競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • 諾和諾德公司
    • Embecta 公司
    • B. Braun SE
    • Owen Mumford
    • BD
    • Cardinal Health
    • SOL-Millennium
    • Terumo Corporation
    • MTD Medical Technology and Devices S.p.A.
    • UltiMed, Inc.
    • Allison Medical, Inc.
Product Code: FBI110437

Growth Factors of pen needles Market

The global pen needles market was valued at USD 2.41 billion in 2025. As per the report timeline, the market is projected to grow to USD 2.56 billion in 2026 and further reach USD 4.58 billion by 2034, registering a CAGR of 7.50% during the 2026-2034 forecast period. North America dominated the global market with a 39.60% share in 2025, supported by high adoption of injectable drug delivery devices and a strong presence of established medical device manufacturers.

Pen needles are disposable medical devices used with injection pens to administer drugs such as insulin, GLP-1 receptor agonists, growth hormone, and other injectable therapies. These needles are replaced after single or limited use, which significantly increases recurring demand. The rising prevalence of chronic diseases such as diabetes, osteoporosis, obesity, and hormone deficiencies is a key contributor to market expansion.

MARKET DRIVERS

The increasing global burden of chronic diseases has been a major driver of pen needle demand. In 2025, diabetes accounted for the largest share of pen needle usage, driven by long-term insulin dependence among patients. The expanding adoption of injectable GLP-1 therapies for diabetes and obesity has further increased reliance on pen-based drug delivery systems.

Market players are actively expanding their product portfolios through acquisitions, partnerships, and new launches. For instance, MTD Medical Technology and Devices S.p.A. strengthened its presence in the pen needle segment by acquiring pen needle and blood glucose monitoring businesses, improving product availability across multiple regions. Additionally, the expansion of over-the-counter (OTC) availability of pen needles in developed markets has supported higher accessibility and volume growth.

MARKET RESTRAINTS

Despite strong demand, the pen needles market faces certain limitations. Risks associated with needlestick injuries, injection-site reactions, and infection transmission remain key concerns for patients and healthcare professionals. Improper injection techniques and repeated injections in the same area can result in complications such as lipohypertrophy and skin infections. Furthermore, the availability of alternative treatment options, including oral medications for diabetes and osteoporosis, continues to restrict market penetration in specific patient groups.

SEGMENTATION ANALYSIS

By Product Type:

Standard pen needles held a dominant position, accounting for 67.97% of the global market share in 2026. Their widespread use is driven by cost-effectiveness and high adoption among diabetes patients. Safety pen needles are expected to grow at a faster pace due to increasing awareness regarding needlestick injury prevention.

By Drug Type:

The insulin segment dominated the market with a 75.39% share in 2026, reflecting the high dependence on insulin for diabetes management. GLP-1 and other injectable drug categories are expected to experience steady growth through 2034.

By Disease Indication:

Diabetes remained the leading disease indication, contributing 83.59% of global demand in 2026. This dominance is supported by rising disease prevalence and continuous innovation in insulin delivery systems by manufacturers.

By Needle Size:

The 4 mm needle segment accounted for 49.61% of the market in 2026, driven by reduced pain perception and lower risk of intramuscular injection. Demand for 6 mm needles is increasing due to their balance between safety and delivery efficiency.

By Distribution Channel:

Retail pharmacies dominated the market in 2025 due to patient preference for easy access and in-store availability. Online pharmacies are projected to grow rapidly through 2034, supported by home delivery convenience and digital healthcare adoption.

REGIONAL INSIGHTS

North America remained the leading region, driven by advanced healthcare infrastructure and strong manufacturer presence. The regional market reached USD 0.96 billion by 2026, supported by companies such as Embecta Corp. and Cardinal Health.

Europe is expected to witness steady growth through 2034, supported by a high prevalence of diabetes and increased preference for self-administered insulin therapies. Asia Pacific is projected to grow at the fastest rate due to expanding patient populations, rising awareness of injectable therapies, and increased pharmaceutical investments in countries such as China, India, and Japan.

KEY INDUSTRY PLAYERS

The competitive landscape includes Novo Nordisk A/S, Terumo Corporation, BD, Owen Mumford, and B. Braun SE. These companies continue to focus on innovation, safety-enhanced designs, and global distribution expansion.

REPORT COVERAGE

The pen needles market report provides detailed insights into market size trends for 2025, 2026, and 2034, along with segmentation analysis, regional outlook, competitive landscape, and the impact of COVID-19. The report also covers key industry developments, including mergers, acquisitions, partnerships, and new product launches influencing market dynamics during the forecast period.

CONCLUSION

The global pen needles market demonstrates consistent expansion across the report timeline, supported by strong demand from chronic disease management and the growing preference for self-administered injectable therapies. With the market valued at USD 2.41 billion in 2025, rising to USD 2.56 billion in 2026, and projected to reach USD 4.58 billion by 2034, growth remains firmly anchored in diabetes care, which accounted for 83.59% of total demand in 2026. The dominance of standard pen needles (67.97% share in 2026) and shorter needle sizes such as 4 mm (49.61% share in 2026) reflects patient preference for cost-effective, low-pain solutions. Regionally, North America's leadership (39.60% share in 2025) highlights the impact of advanced healthcare infrastructure and high adoption of injection pens. Continued innovation, portfolio expansion, and broader accessibility through retail and online pharmacies are expected to sustain market momentum through 2034.

Segmentation By Product Type

  • Standard Pen Needles
  • Safety Pen Needles

By Drug Type

  • Insulin
  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication

  • Diabetes
  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Type, By Disease Indication, By Needle Size, By Distribution Channel, and by Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Standard Pen Needles
    • 5.1.2. Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Needle Size
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Standard Pen Needles
    • 6.1.2. Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Needle Size
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Standard Pen Needles
    • 7.1.2. Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Needle Size
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Standard Pen Needles
    • 8.1.2. Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Needle Size
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. Australia
    • 8.6.4. India
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Standard Pen Needles
    • 9.1.2. Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Needle Size
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Standard Pen Needles
    • 10.1.2. Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Needle Size
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
    • 10.6.2. GCC
    • 10.6.3. Rest of Latin America

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk A/S
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Embecta Corp.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. B. Braun SE
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Owen Mumford
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BD
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Cardinal Health
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SOL-Millennium
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Terumo Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. MTD Medical Technology and Devices S.p.A.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. UltiMed, Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Allison Medical, Inc.
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 3: Global Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 4: Global Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 5: Global Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 6: Global Pen Needles Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: North America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 9: North America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 10: North America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 11: North America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 12: North America Pen Needles Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 15: Europe Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 16: Europe Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 17: Europe Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 18: Europe Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 21: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 22: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 23: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 24: Asia Pacific Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 27: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 28: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 29: Latin America Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Latin America Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 33: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 34: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 35: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 36: Middle East & Africa Pen Needles Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Pen Needles Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 4: Global Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 5: Global Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 6: Global Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 7: Global Pen Needles Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 9: North America Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 11: North America Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 12: North America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 13: North America Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 14: North America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 15: North America Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 16: North America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 17: North America Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 18: North America Pen Needles Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America Pen Needles Market Value Share (%), By Country, 2025
  • Figure 20: Europe Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 21: Europe Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 23: Europe Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 24: Europe Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 25: Europe Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 26: Europe Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 27: Europe Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 28: Europe Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 29: Europe Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 30: Europe Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 35: Asia Pacific Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 36: Asia Pacific Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 37: Asia Pacific Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 38: Asia Pacific Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 39: Asia Pacific Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 40: Asia Pacific Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 41: Asia Pacific Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 42: Asia Pacific Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 45: Latin America Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 47: Latin America Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 48: Latin America Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 49: Latin America Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 50: Latin America Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 51: Latin America Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 52: Latin America Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 53: Latin America Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 54: Latin America Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Pen Needles Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 59: Middle East & Africa Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 60: Middle East & Africa Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 61: Middle East & Africa Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 62: Middle East & Africa Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 63: Middle East & Africa Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 64: Middle East & Africa Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 65: Middle East & Africa Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 66: Middle East & Africa Pen Needles Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Pen Needles Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Pen Needles Market Share (%), By Company, 2025